How To Read Pulmonary Function Test Results: A Step-by-Step Clinical Interpretation Guide

Reading pulmonary function test (PFT) results requires a systematic analysis of spirometry, lung volumes, and diffusing capacity against predicted reference values. Clinicians determine the presence of obstructive or restrictive ventilatory defects by evaluating the FEV1/FVC ratio against the Lower Limit of Normal (LLN) or a fixed threshold of 0.70, followed by Total Lung Capacity (TLC) to confirm restriction, and DLCO to assess gas exchange efficiency.

Pre-Interpretation Standards and Reference Guidelines

Before analyzing a patient's pulmonary function test (PFT) printout, you must establish the baseline parameters and reference standards used to generate the report. PFTs do not use absolute universal normal ranges; instead, they compare a patient’s raw measurements against predicted values calculated from healthy individuals of the same age, height, sex, and biological race. Modern interpretations utilize the Global Lung Function Initiative (GLI) multi-ethnic reference equations to minimize demographic bias and improve diagnostic accuracy.

Essential Evaluation Checklist

• Required Reference Tools and Inputs: Complete patient demographics (exact age, measured height in centimeters, biological sex, and self-reported race), GLI reference tables or software integration, and previous PFT reports for longitudinal comparison.
• Mandatory Quality Control Standards: Verification of daily calibration logs for the pneumotachometer and plethysmograph, and adherence to the joint American Thoracic Society (ATS) and European Respiratory Society (ERS) standardization guidelines.
• Estimated Interpretation Duration: 10 to 15 minutes of detailed analysis per patient record.

Systematic Clinical Algorithm for PFT Interpretation

To prevent diagnostic errors, you must interpret PFT results using a rigid, sequential algorithm. Jumping directly to individual values like Forced Expiratory Volume in 1 second (FEV1) without evaluating the overall relationship of lung volumes often leads to misclassifying mixed defects or overlooking poor patient effort.

Step 1: Validate Test Quality and Acceptability Criteria

Prior to interpreting any data, analyze the flow-volume loop and volume-time curve to ensure the patient met ATS/ERS acceptability and repeatability standards. If the raw data is flawed, the interpreted results will be clinically misleading.

1. Examine the Flow-Volume Loop: Look for a sharp, rapid peak in expiratory flow (Peak Expiratory Flow, or PEF) and a smooth, continuous descent to the horizontal axis (residual volume). A rounded or delayed peak indicates submaximal effort.
2. Verify Exhalation Duration: Ensure the patient exhaled for at least 6 seconds (or 3 seconds in children under 6 years of age) and achieved an expiratory plateau where volume change is less than 0.025 Liters for at least 1 second.
3. Check for Artifacts: Inspect the curves for evidence of coughing during the first second, early termination of effort, glottic closure, or air leaks around the mouthpiece.
4. Confirm Repeatability: Ensure the two largest Forced Vital Capacity (FVC) measurements and the two largest FEV1 measurements are within 150 milliliters (or 0.15 Liters) of each other across at least three acceptable trials.

Warning: Do not attempt to interpret a PFT that fails repeatability or acceptability criteria. Doing so risks misdiagnosing a healthy patient with a restrictive defect due to early exhalation termination, or missing early-stage obstructive disease.

Step 2: Evaluate the FEV1/FVC Ratio to Identify Obstruction

The FEV1/FVC ratio is the primary tool used to identify airflow obstruction. This ratio represents the proportion of the patient's vital capacity that can be expired in the very first second of a forced exhalation.

1. Locate the Pre-Bronchodilator FEV1/FVC Ratio: Look for this value in the "Actual" or "Measured" column of the spirometry section. It is typically expressed as a percentage or a decimal.
2. Compare Against the Lower Limit of Normal (LLN): If the patient's actual FEV1/FVC ratio is below the LLN (typically the 5th percentile of the reference population), an obstructive defect is present.
3. Alternative Fixed Threshold Method: In older guidelines or in specific clinical settings like COPD management (GOLD criteria), a fixed FEV1/FVC ratio of less than 0.70 (70%) is used to define obstruction. Be aware that using a fixed 0.70 ratio can overdiagnose healthy elderly patients and underdiagnose young adults.

Step 3: Determine the Severity of Obstruction using FEV1

If Step 2 confirms the presence of an obstructive ventilatory defect, you must grade its severity. This is determined by looking at the patient’s FEV1 percent predicted value, not the absolute volume in liters.

1. Locate the FEV1 % Predicted: Find the "FEV1" row and trace it to the "% Predicted" column.
2. Apply the Severity Grading Scale:
   
   
   • Mild: FEV1 is greater than or equal to 80% of the predicted value.
   • Moderate: FEV1 is between 50% and 79% of the predicted value.
   • Severe: FEV1 is between 30% and 49% of the predicted value.
   • Very Severe: FEV1 is less than 30% of the predicted value.

Step 4: Assess for Bronchodilator Responsiveness

A bronchodilator reversibility test helps differentiate between asthma and COPD, though significant overlap exists. This step evaluates whether the airway obstruction is acute and reversible.

1. Locate the Post-Bronchodilator Columns: Find the columns labeled "Post-Rx" or "Post-BD", which display measurements taken 10 to 15 minutes after administering an inhaled short-acting beta-2 agonist (such as 4 puffs of albuterol).
2. Calculate the Percentage and Absolute Volume Change:
   
   
   • Use the formula: Percentage Change = ((Post-BD FEV1 - Pre-BD FEV1) / Pre-BD FEV1) x 100.
   • Identify the absolute change in milliliters: Post-BD FEV1 (L) - Pre-BD FEV1 (L).
3. Determine if Reversibility is Present: A positive bronchodilator response requires an increase in either FEV1 or FVC of more than 12% and an absolute increase of more than 200 milliliters from the baseline measurement.

Pro-Tip: A lack of bronchodilator responsiveness does not completely rule out asthma, nor does a positive response entirely exclude COPD. Always correlate these findings with the patient's clinical history and symptoms.

Step 5: Analyze Total Lung Capacity (TLC) to Identify Restriction

If the FEV1/FVC ratio is normal or elevated, but the FVC is reduced, you cannot immediately diagnose a restrictive defect. A low FVC can be caused by either restriction (true loss of lung volume) or severe obstruction with hyperinflation and air trapping (pseudorestriction). To confirm restriction, you must analyze lung volumes measured via body plethysmography, nitrogen washout, or helium dilution.

1. Locate the Total Lung Capacity (TLC): Find the "TLC" value under the lung volumes section of the report.
2. Compare Against the Normal Range: A normal TLC is between 80% and 120% of the predicted value, or above the LLN.
3. Confirm Restrictive Pattern: If the TLC is less than 80% predicted (or less than the LLN), a restrictive defect is confirmed. If the FVC was low but the TLC is normal, the patient does not have a restrictive lung disease.
4. Grade Restrictive Severity:
   
   
   • Mild Restriction: TLC is 65% to 79% predicted.
   • Moderate Restriction: TLC is 50% to 64% predicted.
   • Severe Restriction: TLC is less than 50% predicted.

Step 6: Evaluate Gas Exchange via Diffusing Capacity (DLCO)

The Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) measures the ability of the lungs to transfer gas from inhaled air across the alveolar-capillary membrane into the red blood cells.

1. Adjust for Hemoglobin Levels: Look for the "DLCO Corrected" or "DLCOc" value. This value adjusts the raw measurement for the patient's hemoglobin level, as anemia artificially lowers DLCO and polycythemia artificially raises it.
2. Assess the DLCO Percentage Predicted:
   
   
   • Normal Diffusing Capacity: DLCO is greater than or equal to 75% or 80% predicted (depending on laboratory standards) up to 120% predicted.
   • Decreased Diffusing Capacity (Less than 80% predicted): Indicates a disruption in the alveolar-capillary membrane, alveolar destruction (emphysema), or pulmonary vascular disease.
   • Increased Diffusing Capacity (Greater than 120% predicted): Can occur in alveolar hemorrhage, left-to-right cardiac shunts, polycythemia, or acute asthma due to increased pulmonary capillary blood volume.

Reference Metrics and Severity Grading Thresholds

To aid in quick clinical decision-making, use the following standardized metrics table to evaluate each major parameter of a PFT report.

Resolving Common PFT Artifacts and Interpretation Pitfalls

Even when quality control software passes a test, subtle physiological or physical anomalies can distort PFT results, leading to misdiagnoses.

Artifact 1: False Restrictive Pattern Due to Submaximal Exhalations

• Root Cause: The patient terminates exhalation before reaching true residual volume, leading to an artificially reduced FVC. Because the FVC is low while the FEV1/FVC ratio remains normal, the spirometry report mimics restriction.
• Actionable Fix: Examine the volume-time curve. If there is no flat plateau for at least 1 second at the end of exhalation, or if the exhalation duration is under 6 seconds, reject the FVC measurement. Order a formal plethysmography test to obtain an accurate TLC, which will show a normal lung volume and rule out true restriction.

Artifact 2: Discrepancy Between FVC and Slow Vital Capacity (SVC)

• Root Cause: In patients with severe emphysema or dynamic airway compression, the force of a rapid exhalation causes early airway closure, trapping air inside the lungs and artificially lowering the FVC. When these patients perform a slow, relaxed exhalation (Slow Vital Capacity or SVC), their airways stay open longer, resulting in a significantly larger volume.
• Actionable Fix: Always look for the SVC value on the report if it is available. If the SVC is larger than the FVC, use the SVC as the denominator to calculate the FEV1/SVC ratio. This prevents you from missing a real obstructive defect that was masked by airway collapse during the forced FVC maneuver.

Artifact 3: False Decrease in DLCO due to Undetected Anemia

• Root Cause: DLCO measurements rely on the binding of carbon monoxide to hemoglobin. If a patient is severely anemic, they have fewer hemoglobin binding sites available, which drops the raw DLCO measurement and falsely suggests a gas-diffusion or interstitial lung disease.
• Actionable Fix: Locate the "DLCO Corrected" (DLCOc) value on the report. Ensure that a recent hemoglobin level (measured within the last 30 days) was entered into the PFT machine before interpretation. If no hemoglobin correction was performed, manually request a blood count and apply the Dinakara correction formula to recalculate the true diffusing capacity.

Frequently Asked Questions

What is the difference between restrictive and obstructive lung disease on a PFT?

Obstructive lung diseases (such as asthma, COPD, and bronchiectasis) impair a patient's ability to exhale air quickly, which manifests as an FEV1/FVC ratio below the Lower Limit of Normal or less than 0.70. Restrictive lung diseases (such as idiopathic pulmonary fibrosis, sarcoidosis, or scoliosis) reduce the physical capacity of the lungs to expand, which is characterized by a normal FEV1/FVC ratio paired with a Total Lung Capacity (TLC) of less than 80% of the predicted value.

How does age, sex, and height affect normal PFT reference values?

PFT reference equations utilize height, age, biological sex, and race to calculate predicted normal lung volumes. Taller individuals have larger thoracic cavities and higher predicted volumes, while lung function naturally declines with age due to loss of chest wall compliance and alveolar elasticity. Biological males typically have larger lung capacities than females of the identical age and height, making demographic matching crucial for accurate interpretation.

What does a low DLCO with normal spirometry and lung volumes mean?

A low DLCO (less than 80% predicted) in the presence of completely normal spirometry and lung volumes suggests a vascular pathology that limits blood flow to the alveoli without damaging the lung tissue itself. Common causes include pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension, early-stage interstitial lung disease, or subclinical emphysema that has not yet altered airway mechanics.

How is a positive bronchodilator response defined?

A positive bronchodilator response is defined by the ATS/ERS guidelines as an increase in either FEV1 or FVC of more than 12% from the pre-bronchodilator baseline, along with an absolute increase of at least 200 milliliters. Both thresholds must be met simultaneously to demonstrate clinically significant airway reversibility.

Elevate Your Clinical Pulmonary Assessment Capabilities

Incorporate these systematic interpretation steps into your daily clinical workflows to improve diagnostic accuracy and prevent common diagnostic errors. For complex patient presentations involving borderline restrictive patterns or unexplained gas exchange deficits, always pair your PFT interpretation with high-resolution computed tomography (HRCT) of the chest.